City snapshot: Reckitt Benckiser agrees $1.4bn US drugs fine

Reckitt Benckiser has agreed to pay a $1.4bn fine to close a US Department of Justice investigation into the sales and marketing of an opioid addiction drug under its former pharma arm. Plus, McBride warns of further sales weakness and all the rest of the latest news from the City.